Charbel Haber joined Moderna in April 2020 as a Senior Vice-President of Regulatory Affairs. In this role, Charbel is responsible of building a global regulatory organization, comprising, Regulatory Operations, Regulatory CMC, and Regulatory Strategy, to support Moderna’s pipeline including the development and registration of Moderna COVID-19 Vaccine. Charbel worked most recently at Biogen, where he was a VP in Global Safety and Regulatory Sciences. Charbel has an extensive and diverse global regulatory background having worked at EMD Serono, Novartis (both in the US and in EU), PTC Therapeutics, MedImmune and Merck.